1 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HFrEF on GDMT ... outcomes in HFrEF ... on GDMT, with or ... #inhibitors #EBM ... #table #CVD #CKD